Medication info

Idian Tablet 25mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Il Yang Pharmaceutical Co., Ltd.
Appearance
Light yellow, oval-shaped film-coated tablet with both sides convex
Packaging
10 tablets/box [10 tablets/PTP x 1], 30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle
Approval status
Active

MFDS item code 202102071 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age and older. Initiation of this medicine is not recommended in patients 85 years of age and older because clinical experience is limited

Ingredients

Manufacturer
Il Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty in controlling blood sugar levels in patients with type 2 diabetes
  • and conditions where blood sugar is not adequately controlled
View approved original text

This medication is used in conjunction with dietary control and exercise to help manage blood sugar levels in adult patients with type 2 diabetes. It can be administered alone, and if adequate control is not achieved with monotherapy, it may be combined with metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors like linagliptin. It can also be used in patients with type 2 diabetes who have cardiovascular diseases, but in this case, it is important to refer to the precautions provided by specialists. This medicine effectively controls blood sugar across various therapeutic combinations, improving diabetes management.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily for monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is required for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well but have a persistent glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This medicine should be discontinued if the glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medicine in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. No dose adjustment is required for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is required based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age and older. Initiation of this medicine is not recommended in patients 85 years of age and older because clinical experience is limited

Precautions

This medication should not be administered to certain patients. First, those with allergic reactions to the active ingredient or any component of this medication should not take it. Second, patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Third, those with severely impaired kidney function, that is, with a glomerular filtration rate of less than 30 mL/min/1.73m2 or those with end-stage renal disease or undergoing dialysis should not take this medication. Fourth, individuals with lactose intolerance, galactose intolerance, or genetic lactase deficiency should not receive this medication as it contains lactose. Patients with slightly impaired kidney function should use this medication cautiously. If the glomerular filtration rate is less than 60 mL/min/1.73m2, it is best to avoid using this medication from the start, and if already in use, dosage adjustments or discontinuation may be necessary. This medication is not used in patients with end-stage renal disease or those undergoing dialysis as efficacy cannot be expected. For patients with heart failure classified as mild to moderate (NYHA class I-II), it should be used with caution, whereas its use is not recommended for those with severe heart failure (NYHA class III-IV). When taken alongside insulin or sulfonylureas, the risk of hypoglycemia may increase, so dosage reductions of insulin or secretagogues may be necessary. Attention should be paid to adverse reactions while taking this medication. Hypoglycemia, genital infections, urinary tract infections, increased urination, decrease in fluid volume, interstitial nephritis, and others may occur. Particularly, serious metabolic acidosis known as ketoacidosis might develop, so if symptoms arise, immediate consultation with medical personnel is essential. Elderly patients, particularly those over 75 years old, are at higher risk of fluid loss, thus caution is advised. This medication can affect liver or kidney function; therefore, periodic kidney function tests are required before and during administration. Women who are pregnant are advised to avoid taking this medication, and upon confirmation of pregnancy, discontinuation of use is recommended. Breastfeeding women are advised to cease breastfeeding while taking this medication. This medication has not been established for safety and efficacy in children under 18 years of age, so it should not be used. No specific toxic symptoms have been reported in the event of overdose; however, in case of overdose, immediate consultation with a medical institution for appropriate treatment is necessary. This medication may interact with other drugs, particularly with diuretics, insulin, and sulfonylureas, thus caution is needed when co-administered. While taking this medication, patients should be careful while driving or operating machinery due to the risk of hypoglycemia. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal necrosis
  • itching
  • rash
  • urticaria
Show 236 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • elevated serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • acute pyelonephritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • ureteral calculi
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • diabetes mellitus
  • hyponatremia
  • diabetic foot
  • lower back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • lattice retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina pectoris
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the Vater ampulla
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic adenocarcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • dental caries
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • gastroenteritis
  • bloating
  • gastric polyp
  • gingival swelling
  • bloody stool
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional vertigo
  • sensory loss
  • perceptual abnormality
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory abnormality
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial swelling
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • puncture site pain
  • weight gain
  • abnormal electrocardiogram
  • hemoglobin decrease
  • hemoglobin increase
  • positive Helicobacter test
  • positive urine red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • somnolence
  • hyperlipidemia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • side pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • conjunctival congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • upper respiratory tract infection
  • herpes zoster
  • dizziness
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in an airtight container to prevent exposure to air or moisture, and it is important to maintain storage temperatures between 1 and 30 degrees Celsius. By adhering to these storage conditions, the medication's effectiveness and safety can be well maintained.

Appearance and packaging

Appearance

Light yellow, oval-shaped film-coated tablet with both sides convex

Package unit

10 tablets/box [10 tablets/PTP x 1], 30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.